Reversible ventricular arrythmia induced by dasatinib

Spechbach, Hervé; Morel, Philippe; Ing Lorenzini, Kuntheavy; Besson, Marie; Getaz, Laurent; Sunthorn, Henri; Chalandon, Yves

doi:10.1002/ccr3.5

Scientific article

Case report

English

Reversible ventricular arrythmia induced by dasatinib

ContributorsSpechbach, Hervé; Morel, Philippe; Ing Lorenzini, Kuntheavy

; Besson, Marie; Getaz, Laurent; Sunthorn, Henri; Chalandon, Yves

Published inClinical case reports, vol. 1, no. 1, p. 20-25

Publication date2013

Abstract

Ventricular arrhythmias induced by dasatinib are rare events, but physicians in charge of chronic myeloid leukemia patients should be aware of such potential complications and the need for regular ECG controls during treatment with tyrosine kinase inhibitors.

Affiliation entities

Research groups

Citation (ISO format)

SPECHBACH, Hervé et al. Reversible ventricular arrythmia induced by dasatinib. In: Clinical case reports, 2013, vol. 1, n° 1, p. 20–25. doi: 10.1002/ccr3.5

Article (Published version)

Identifiers

PID : unige:55997
DOI : 10.1002/ccr3.5
PMID : 25356203

Journal ISSN2050-0904

660views

255downloads

Creation01/05/2015 13:10:00

First validation01/05/2015 13:10:00

Update14/03/2023 23:15:10

Status update14/03/2023 23:15:10

Last indexation19/11/2024 15:02:38

Archive ouverte UNIGE

Reversible ventricular arrythmia induced by dasatinib

Ventricular arrhythmias induced by dasatinib are rare events, but physicians in charge of chronic myeloid leukemia patients should be aware of such potential complications and the need for regular ECG controls during treatment with tyrosine kinase inhibitors.

Technical informations